Pathogenesis of Endometriosis: New Insights into Prospective Therapies
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Endometriosis is a female reproductive disorder characterized by growth of uterine cells and tissue in distant sites. Around 2–10% of women experience this condition during reproductive age, 35–50% of whom encounter fertility issues or pain. To date, there are no established methods for its early diagnosis and treatment, other than surgical procedures and scans. It is difficult to identify the disease at its onset, unless symptoms such as infertility and/or pain are present. Determining the mechanisms involved in its pathogenesis is vital, not only to pave the way for early identification, but also for disease management and development of less invasive but successful treatment strategies. Endometriosis is characterized by cell proliferation, propagation, evasion of immunosurveillance, and invasive metastasis. This review reports the underlying mechanisms that are individually or collectively responsible for disease establishment and evolution. Treatment of endometriosis mainly involves hormone therapies, which may be undesirable or have their own repercussions. It is therefore important to devise alternative strategies that are both effective and cause fewer side effects. Use of phytochemicals may be one of them. This review focuses on pharmacological inhibitors that can be therapeutically investigated in terms of their effects on signaling pathways and/or mechanisms involved in the pathogenesis of endometriosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations
Taylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00389-5 · Cited by 1,425
Nisolle, M., & Donnez, J. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00191-x · Cited by 1,279
Vascular endothelial growth factor (VEGF) in endometriosis
Donnez, J., Smoes, P., Gillerot, S., Casanas-Roux, F., & Nisolle, M. (1998) · Human Reproduction · doi:10.1093/humrep/13.6.1686 · Cited by 531 · cited 7×
“Various reports in the literature describe increased expression of VEGF, MMP2, and MMP9 in endometriotic lesions in rats, mice, and peritoneal fluid from patients.”
BackgroundInfluentialHan, S. J., Jung, S. Y., Wu, S.-P., Hawkins, S. M., Park, M. J., Kyo, S., Qin, J., Lydon, J. P., Tsai, S. Y., Tsai, M.-J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.034 · Cited by 380
Endometriosis and nuclear receptors
Yilmaz, B. D., & Bulun, S. E. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz005 · Cited by 243 · cited 4×
“In endometriosis, when cells or tissue from the endometrium attach to non-native sites, there is an altered efficiency of progesterone and estrogen hormones, generally resulting in resistance to progesterone and an excess of estrogen [50,51].”
BackgroundInfluentialDonnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051085 · Cited by 182 · cited 2×
“In endometriosis, when cells or tissue from the endometrium attach to non-native sites, there is an altered efficiency of progesterone and estrogen hormones, generally resulting in resistance to progesterone and an excess of estrogen [50,51].”
BackgroundSelf-citationInvolvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis
González-Ramos, R., Van Langendonckt, A., Defrère, S., Lousse, J.-C., Colette, S., Devoto, L., & Donnez, J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.01.013 · Cited by 179
Bengtsson, A. K., Ryan, E. J., Giordano, D., Magaletti, D. M., & Clark, E. A. (2004) · Blood · doi:10.1182/blood-2003-10-3380 · Cited by 161
Horie, S., Harada, T., Mitsunari, M., Taniguchi, F., Iwabe, T., & Terakawa, N. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.042 · Cited by 146
Xiong, Y., Liu, Y., Xiong, W., Zhang, L., Liu, H., Du, Y., & Li, N. (2016) · Human Reproduction · doi:10.1093/humrep/dew081 · Cited by 105
Cited by
The Main Theories on the Pathogenesis of Endometriosis
Lamceva, J., Uljanovs, R., & Strumfa, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054254 · Cited by 324
“In case of endometriosis, proinflammatory pathways block functions of apoptotic mechanisms, and potentially harmful cells adhere to distant sites [20].”
BackgroundInfluentialNezhat, C. R., Oskotsky, T. T., Robinson, J. F., Fisher, S. J., Tsuei, A., Liu, B., Irwin, J. C., Gaudilliere, B., Sirota, M., Stevenson, D. K., et al. (2025) · npj Women s Health · doi:10.1038/s44294-024-00052-w · Cited by 25
Neamtu, R., Dahma, G., Mocanu, A. G., Bernad, E., Silaghi, C.-I., Stelea, L., Citu, C., Dobrescu, A., Bratosin, F., Grigoras, M. L., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19052791 · Cited by 12
“Cesarean scars such as skin and uterine scars, trocar insertion sites, sigmoid colon, ovaries, bladder, vaginal vault, and parietal peritoneum are the most prevalent locations for IE [2,3].”
BackgroundUrinary Tract Endometriosis: How to Predict and Prevent Recurrence after Primary Surgical Excision
Di Maida, F., Lambertini, L., Grosso, A. A., Mari, A., Vannuccini, S., Capezzuoli, T., Fambrini, M., Petraglia, F., & Minervini, A. (2022) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2022.07.004 · Cited by 5
Metadata
- Authors
- Kapoor, R., Stratopoulou, C. A., & Dolmans, M.-M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-10-28
- Volume
- 22
- Issue
- 21
- Pages
- 11700
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3210148138
- Cited by
- 143
- References
- 11
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.